Breakthrough cardiac arrest treatment with the first intelligent fluoroscopy-free balloon catheter
Neurescue is a medical device startup pioneering an improved treatment of cardiac arrest, the leading cause of death in the world.
The NEURESCUE device is used to inflate a balloon in the descending aorta through a femoral artery introducer sheath. It is the world’s first intelligent balloon catheter for temporary aortic occlusion.
Temporary aortic occlusion is an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The NEURESCUE device's simple design is optimized for emergency situations.
This can increase the chance of immediate resuscitation, and bridge the patient to additional life-saving treatment options, such as surgery, PCI, heart-lung machine, and more.
Cardiac arrest is a major health problem accounting for an estimated 15-20% of all deaths.
In the United States 40-50% of all lost life years from heart disease is due to cardiac arrest. Cardiac arrest is leading cause of lost life years within heart diseases.
Today's CPR only replaces 35% of blood flow, which is not enough to resuscitate most patients; and does not buy enough time to bridge patients to advanced treatments.
Don't hesitate to get in touch.
This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 811866
Antonigade 11, 2nd floor,
45 Albemarle Street, 3rd floor,
Mayfair, W1S 4JL, London
Saving hearts and minds